Researchers at the George Washington University published research finding that certain symptoms are more and less predictive of patients’ risk for acute coronary syndrome, which includes heart attack, in patients of different gender and race.
Going for a walk outside, reading, listening to music—these and other enjoyable activities can reduce blood pressure for elderly caregivers of spouses with Alzheimer’s disease, suggests a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. The journal is published by Wolters Kluwer.
Women and their physicians are largely uneducated when it comes to females and heart disease, putting women’s health and lives at greater risk, a new study out today shows. The study, published in the Journal of the American College of Cardiology, shows that 45 percent of U.S. women are not aware that heart disease is the No. 1 killer of women.
Results from four recent randomized clinical trials suggest that using medications that offer glucose control while reducing the risk for cardiovascular disease could improve patient outcomes.
In a Canadian first, a medical team has implanted a wireless device inside a heart failure patient, permitting clinicians to monitor the patient’s cardiovascular status – virtually and in real-time – and proactively adjust treatment to prevent costly, potentially unnecessary hospitalization.
In a new video posted today, Cedars-Sinai heart expert Evan Zahn, MD, explains a new treatment for babies born with patent ductus arteriosus, a “hole in the heart,” the most common structural heart defect in newborns. The video is available for streaming and downloading.
Heart health in children will be the focus of three closely synergistic research projects and an integrated multidisciplinary training program, that are newly funded by a $3.7 million four-year grant led by Bradley S. Marino, MD, MPP, MSCE, a pediatric cardiologist from Ann & Robert H. Lurie Children’s Hospital of Chicago and Professor of Pediatrics and Medical Social Sciences at Northwestern University Feinberg School of Medicine. As one of only four centers selected to participate in the American Heart Association’s Strategically Focused Children’s Research Network, research by Marino and colleagues will provide evidence for innovative policies, programs and practices to preserve cardiovascular health in childhood and beyond.
Doctors at The Ohio State University are testing a high-tech vest which measures fluid inside the lungs from outside a person’s clothing. It could be a new way to prevent repeated trips to the hospital for the nearly six million Americans living with heart failure.
Patients who are at risk for malnutrition when undergoing heart surgery now can be more quickly and easily identified, leading to intervention and potentially better surgical outcomes, according to a study published online today in The Annals of Thoracic Surgery.
In a new study, UCLA researchers hypothesized that simple biomarkers — urinary stress hormones dopamine, epinephrine and norepinephrine, and cortisol — would be associated with more calcium buildup in the coronary arteries, which indicates the presence of coronary heart disease, and that this effect would be stronger in women than in men.
However, the researchers found that this relationship was actually similar in women and men: Although women had higher average levels of urine stress hormones than men, the association between stress and having asymptomatic coronary heart disease as measured by coronary calcium was similar in both genders. In particular, urinary cortisol was a strong independent predictor of asymptomatic coronary heart disease.
Congressman Ami Bera, MD (D-CA) was given the Legislator of the Year Award by The Society of Thoracic Surgeons Monday evening in recognition of his strong legislative record on issues that help cardiothoracic surgeons provide the best possible care to their patients.
About a quarter of Americans suffer hardening of the valves by age 65 and about half by 85. Without a suitable drug, the only treatment is surgical replacement.
Timothy A.M. Chuter, BM BS, DM, FACS, was honored with this international surgical award in recognition of his innovative role in the development of endovascular aneurysm repair.
A study by the University of Birmingham has revealed a treatment gap in patients suffering from a heart condition that causes an irregular or abnormally fast heartbeat.
Researchers examined if a particular trial type could be successfully applied to stroke patients — and whether this approach may accelerate discovery of new treatments.
Shortly after birth, hearts are no longer able to repair damage. Weizmann Institute scientists found a molecule in newborn hearts that appears to control the renewal process, and seems to “unlock” it in adult hearts; this has important implications for restoring the function of damaged hearts.
Although lifestyle contributes to heart disease, genetics play a major role. This genetic facet has remained largely mysterious. But new research by scientists at the University of Maryland School of Medicine has identified what may be a key player: a mutated gene that leads to irregular heartbeat, which can lead to a dangerously inefficient heart.
ROCHESTER, Minn. —Mayo Clinic researchers report that women who suffered adverse childhood experiences or abuse as an adult are 62 percent more likely to have their ovaries removed before age 46. These removals are for reasons other than the presence of ovarian cancer or a high genetic risk of developing cancer, says the new study published today in BMJ Open.
Expanding Medicaid coverage is associated with better outcomes for heart surgery patients, according to a study led by University of Virginia School of Medicine researchers.
Results of an international, randomized controlled research study show that mechanical thrombectomy, which is an endovascular treatment to remove a stroke-causing blood clot in the brain, is effective in some patients even when performed within 6 to 24 hours after a stroke.
Rush University Medical Center is offering a new, implantable cardiac device to reduce the risk of stroke in patients with atrial fibrillation, providing an alternative to the long-term use of blood thinners.
For some patients, statins cause necrotizing myopathy, a form of the rare, chronic, debilitating condition idiopathic inflammatory myopathy, also known as myositis.
Medical emergencies cause a high number of vehicle crashes. University of Michigan researchers have teamed up with Toyota to examine whether new vehicle technology could predict — and potentially prevent — such scenarios.
A groundbreaking study published today in AACC’s Journal of Applied Laboratory Medicine shows that a new test could improve diagnosis and treatment of heart disease by measuring how effectively a patient’s high-density lipoprotein cholesterol (HDL-C) cleans up arterial cholesterol.
Almost 1 in 6 of the millions of Americans on the new blood-thinning medications for atrial fibrillation, a common heart condition characterized by an irregular and often rapid heart rate, may not be receiving the recommended dose, new Mayo Clinic research finds.
Author says empowering patients with individualized information, and involving them in shared decision-making, is how one makes the best decisions in cases of significant LMD.
One additional injection of insulin three hours after eating has been shown to protect people with type 1 diabetes from cardiovascular disease – the leading cause of death among people with the condition
Dr. Ralf Holzer, a pediatric cardiologist and expert in minimally invasive techniques to treat children and adults with congenital heart disease, has been named chief of the Division of Pediatric Cardiology at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, and director of Pediatric Cardiac Catheterization at The Komansky Children’s Hospital, effective June 1.
The Cardiovascular Research Foundation (CRF) will hold a free seminar “Broken Hearts: Living with Heart Failure” on Tuesday, June 6, 2017 for heart failure patients and caregivers at New York-Presbyterian Hospital. The seminar, part of a series of Mini-Med School seminars conducted by the CRF Women’s Heart Health Initiative, will focus on providing both patients and caregivers a deeper understanding of heart failure, its symptoms, and treatment options.
A technique to treat an irregular heartbeat that limits or eliminates patients’ exposure to radiation should be more widely adopted by physicians, NewYork-Presbyterian and Weill Cornell Medicine cardiologists argue in a new review article in Heart Rhythm, published in the June print issue and previously published online.
Patients who undergo the Fontan operation as children for a complex congenital heart defect are at risk of developing progressive liver fibrosis, a buildup of fibrous deposits, as a result of the circulation created by the surgery. A research team says their findings underscore the importance of improving ongoing medical surveillance, so that physicians can develop the most appropriate care for their patients.
A new study conducted by researchers from Tulane University finds reducing target systolic blood pressure below current recommendations significantly reduces the risk of cardiovascular disease and preventable death.
For more than two months, Kim O’Neill, 61, spent nearly every night lying in bed, staring at the ceiling and wondering if she was going to die in her sleep. Her heart was beating so loudly in her chest she thought it might explode. During the day, she would struggle to walk up a flight of stairs to the second floor of her home and would run out of breath in the middle of a conversation with her husband. A typically active and positive person, O’Neill was terrified that this was her new normal.
Everything changed in December 2016 when she met Ramesh Hariharan, M.D., a cardiac electrophysiologist with McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) and Memorial Hermann The Woodlands Hospital.
It may be possible to disrupt harmful blood clots in people at risk for heart attack or stroke without increasing their risk of bleeding, according to a new study published in Nature Communications.
Temple University Hospital has earned the Mission: Lifeline® Silver Receiving Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association for the treatment of patients who suffer severe heart attacks.
Researchers in Japan have identified a receptor protein on the surface of heart cells that promotes chronic heart failure. The study, “Corticotropin releasing hormone receptor 2 exacerbates chronic cardiac dysfunction,” which will be published May 26 in The Journal of Experimental Medicine, suggests that inhibiting this protein could help treat a disease that affects more than 20 million people worldwide.
The reduced-size Amplatzer duct occluder II (ADO II), a heart device developed to repair one of the most common congenital heart defects, is safe to use in very small children. That’s according to new research published in the May 2017 issue of Catheterization and Cardiovascular Intervention.
Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) today announced six boxes of fruit flies (Drosophila melanogaster) will travel to the International Space Station (ISS) to study the impact of weightlessness on the heart. The fruit flies are scheduled to launch on June 1, 2017, from NASA’s Kennedy Space Center and will travel to the ISS via a SpaceX Dragon spacecraft.
Thousands of critical care and pulmonology specialists from across the world gathered this week for the American Thoracic Society International Conference in Washington, D.C., to share research, medical developments and best practices for patient care. Here, we highlight a few standouts.
New Michigan State University research is the first to help a professional race car driver with diabetes improve his performance during competition, helping him capture two top-5 finishes at the Indianapolis 500.
Dr. Ming-Hui Zou, director of the Center for Molecular & Translational Medicine and a Georgia Research Alliance Eminent Scholar in Molecular Medicine, has renewed a four-year, $2.3 million federal grant to study the role of an enzyme in causing diabetic vascular diseases and the molecular mechanism that leads to these diseases.
A new strategy – an injectable antibody – for lowering blood lipids and thereby potentially preventing coronary artery disease and other conditions caused by the build-up of fats, cholesterol, and other substances on the artery walls, is supported by findings from two new studies from researchers in the Perelman School of Medicine at the University of Pennsylvania.
Two stressful work characteristics, low job control and “job strain” – that is, high-demand, low-control work – have been increasing in the U.S. since 2002. The findings may explain why declines in cardiovascular disease and related mortality have slowed. Researchers also found an increase in "work-family conflict."
Garret FitzGerald, MD, FRS, director of the Institute for Translational Medicine and Therapeutics in the Perelman School of Medicine at the University of Pennsylvania, has received a $1 million Merit Award from the American Heart Association (AHA) to help the millions of patients with high blood pressure improve their condition.
Chocolate consumption, particularly of dark chocolate, has been linked to improvements in various indicators of heart health. This study examined the possible association between chocolate intake and a lower rate of being diagnosed with atrial fibrillation. While this is an observational study, researchers believe these findings warrant further consideration to identify effective prevention strategies for atrial fibrillation.
Children’s Hospital of Philadelphia is proud to announce that Joseph Rossano, M.D., has been named Chief of the Division of Cardiology, effective this week.